UV spectrophotometric methods for simultaneous determination of ketorolac tromethamine and olopatadine hydrochloride: Application of multiple standard addition for assay of ophthalmic solution.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
24 10 2023
24 10 2023
Historique:
received:
18
06
2023
accepted:
18
10
2023
medline:
26
10
2023
pubmed:
25
10
2023
entrez:
24
10
2023
Statut:
epublish
Résumé
Ophthalmic preparations that contain ketorolac tromethamine (KET) and olopatadine HCl (OLO) are used to relieve seasonal allergies and allergic conjunctivitis. Simultaneous quantification of KET and OLO was held by validated and simple spectrophotometric methods. KET was determined directly from the fundamental UV absorption spectra (at 323 nm), while OLO was determined after performing either dual wavelength or ratio derivative methods. The first method was based on measuring the absorbance difference (ΔA) between 243 and 291 nm, while the second depended on generating first derivative ratio spectra using 3.0 µg/mL KET as a divisor and measuring OLO responses at 234 nm (minima). Multiple standard addition method was applied to enable the determination of OLO which is considered as the weakly absorbing species as well as the minor component in a challenging dosage form ratio (4:1). The linearity ranges of the developed methods were 3-12 μg/mL and 4-40 μg/mL for KET and OLO, respectively. Simultaneous determination of both drugs was successfully implemented to lab prepared eye drops that contain KET, OLO and benzalkonium chloride as an inactive ingredient. Greenness assessment indicates minimal impact on environment. The developed methods determined the cited drugs with % recovery ± SD of 99.63 ± 0.01 for KET, 100.90 ± 0.02 and 100.31 ± 0.01 for OLO using dual wavelength and first derivative ratio methods, respectively. Using F-test and t-test at confidence level %95 to compare between the results of the presented methods and a reported method show no significant difference which allows precise, accurate, rapid, and simple quantification of quality control samples that contain KET and OLO.
Identifiants
pubmed: 37875539
doi: 10.1038/s41598-023-45378-8
pii: 10.1038/s41598-023-45378-8
pmc: PMC10598205
doi:
Substances chimiques
Olopatadine Hydrochloride
2XG66W44KF
Ketorolac Tromethamine
4EVE5946BQ
Ophthalmic Solutions
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18143Informations de copyright
© 2023. Springer Nature Limited.
Références
Chem Cent J. 2017 May 25;11(1):43
pubmed: 29086829
J AOAC Int. 2022 Sep 6;105(5):1247-1257
pubmed: 35686891
Saudi Pharm J. 2013 Oct;21(4):411-21
pubmed: 24227962
Spectrochim Acta A Mol Biomol Spectrosc. 2015;151:628-43
pubmed: 26163786
Ann Pharm Fr. 2016 Jul;74(4):267-82
pubmed: 26895689
Talanta. 2018 May 1;181:204-209
pubmed: 29426502
Arzneimittelforschung. 2004;54(12):809-29
pubmed: 15646365
Drug Dev Ind Pharm. 2014 Sep;40(9):1190-8
pubmed: 23829222
J Chromatogr B Biomed Sci Appl. 2001 May 5;755(1-2):383-6
pubmed: 11393731
J Chromatogr Sci. 2016 May-Jun;54(5):819-28
pubmed: 26847918